GREY:TSTIF - Post by User
Post by
echo2on Apr 10, 2017 12:14pm
363 Views
Post# 26100908
FDA Shifting to Post-Market Evaluation Emphasis...?
FDA Shifting to Post-Market Evaluation Emphasis...?https://www.aami.org/newsviews/newsdetail.aspx?ItemNumber=4271
"Such a system would also allow manufacturers to compile data about the safety and effectiveness of devices being used under "real-world" conditions, which could be used to support a label extension." - See more at: https://www.aami.org/newsviews/newsdetail.aspx?ItemNumber=4271#sthash.0e6MFXve.dpuf
Such changes will help to speed the FDA's label extensions for the VP4, especially as TSO3 works closely with scope manufacturers to provide health care providers with a proven and improved standard of care!!